N-Methyl-2-[2-(1-methylpiperidin-4-ylidene)hydrazin-1-yl]pyridine-3-sulfonamide

Catalog No. :
ACGKYS606
CAS No. :
1774905-70-2
Molecular Formula :
C12H19N5O2S
Molecular Weight :
297.38

IUPAC Name:N-methyl-2-(2-(1-methylpiperidin-4-ylidene)hydrazineyl)pyridine-3-sulfonamide

N-Methyl-2-[2-(1-methylpiperidin-4-ylidene)hydrazin-1-yl]pyridine-3-sulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Methyl-2-[2-(1-methylpiperidin-4-ylidene)hydrazin-1-yl]pyridine-3-sulfonamide
IUPAC NameN-methyl-2-(2-(1-methylpiperidin-4-ylidene)hydrazineyl)pyridine-3-sulfonamide
MDL No.MFCD26130042
Molecular FormulaC12H19N5O2S
Molecular Weight297.38
SMILESO=S(C1=CC=CN=C1NN=C2CCN(C)CC2)(NC)=O
InChI KeyZKDBTCXLWPGDLE-UHFFFAOYSA-N
Synonym2-[N-(1-Methyl-piperidin-4-ylidene)-hydrazino]-pyridine-3-sulfonic acid methylamide;3-Pyridinesulfonamide, N-methyl-2-[2-(1-methyl-4-piperidinylidene)hydrazinyl]-
CAS No.1774905-70-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGKYS606 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGKYS606 route product structure diagram
    ACGKYS6061774905-70-2
Inquiry

2. ACGKYS606 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGKYS606 route product structure diagram
    ACGKYS6061774905-70-2
Inquiry

Comments (0)